1 The abbreviations used were: hmft gene, human mitochondrial folate transporter gene; dbEST, espressed sequence tag database; TM, transmembrane domain; ES, energy signal domain; PCR, polymerase chain reaction; SHMT, serine hydroxymethyltransferase. In mammalian cells, the processes of folate metabolism are distributed between the cytosolic and mitochondrial compartments (1). Mitochondrial folates amount to about 35 % of the total cellular pool (2,3) and are used as cofactors for a mitochondrial serine hydroxymethyltransferase (SHMT), by the glycine cleavage system, and for the synthesis of the formylmethionine initiator of mitochondrial protein synthesis.
In mammalian cells, the processes of folate metabolism are distributed between the cytosolic and mitochondrial compartments (1) . Mitochondrial folates amount to about 35 % of the total cellular pool (2, 3) and are used as cofactors for a mitochondrial serine hydroxymethyltransferase (SHMT), by the glycine cleavage system, and for the synthesis of the formylmethionine initiator of mitochondrial protein synthesis.
The transport of folates through the plasma membrane into the cytosol has been extensively studied (4) (5) (6) , and two of the transport systems have been cloned (7, 8) . In contrast, the mechanism of transfer of folates into mitochondria, presumably from the cytosol, is largely unknown as is the release of folates back to the cytosol from the mitochondria. Once folate monoglutamates, the form of folate found in the circulation, enter mammalian cells they are quickly metabolized to poly-γ-glutamate derivatives by cytosolic folylpolyl-γ-glutamate synthetase (FPGS), a process needed to promote retention of folate cofactors in cells (9) . FPGS is also present in the mitochondrial compartment of mammalian cells (10) , translated from transcripts from the FPGS gene which add a mitochondrial leader sequence to the coding region of the protein found in the cytosol (11, 12) . Two studies have demonstrated the penetration into isolated mitochondria by folates in a process that was saturable and temperature dependent (13, 14) . These studies would support the existence of a transporter responsible for entry of folates into the mitochondria, as does the fact that cells which either lack mitochondrial FPGS (11) or are incapable of accumulation of mitochondrial folates (15) are glycine auxotrophs.
Early studies by Puck and his colleagues selected somatic cells auxotrophic for glycine and demonstrated that they fell into four complementation groups, named gly A through D (16, 17) . Gly A was found to be due to a deficiency in mitochondrial SHMT (17, 18) . The Gly C and D mutations have not, to our knowledge, been assigned to functions. Gly B cells had normal cytosolic folate metabolism and enzymes and the same mitochondrial SHMT and FPGS as CHO cells, but lacked mitochondrial folates (15) . The most likely candidate for the function missing in glyB cells was a transport protein which faciliated the entry of folates into mitochondria.
We have transferred a library of human cDNAs in a retroviral vector into glyB cells and isolated a transduced cell line no longer auxotrophic for glycine. These cells contained a human cDNA which, when rescued by PCR and recloned into a mammalian expression plasmid, complemented the auxotrophy of glyB cells at high frequency and also reinstated folate entry into mitochondria. We conclude that we have isolated the human gene encoding the inner membrane protein responsible for entry of folates into mitochondria.
Materials and Methods
Cell culture. Cells were grown in 37°C in 5% CO2. The glyB cell line, which was derived from CHO-K1 cells (16, 17) , was a generous gift of Dr Lawrence Chasin (Columbia University, NY, NY). HEK293gp packaging cells (a gift from Dr Oliver Bogler of this University) were grown in DMEM, glyB and CHO-K1 in MEM, and CEM in RPMI-1640, all containing 10 % fetal calf serum. For virus production, HEK293gp cells were plated at 5 x10 6 cells on each of twelve 100 mm dishes. Forty eight hours later, 15 µg of plasmid library DNA, 15 µg of pVSVG plasmid (Dr Oliver Bogler), which allows pseudeotyping of the viral envelope proteins (19, 20) , and 55 µg of Lipofectamine-2000 (Life Technologies) were added to each dish in DMEM. After 20 min at room temperature, the medium was replaced with 25 µM chloroquine in DMEM and 1.5 ml of the lipid-DNA complex was added to each plate. Media was changed to complete DMEM after 5 h at 37 °; the supernatant, containing the collection of viruses from the library, was harvested after 36 and 72 hours and filtered. Transduction efficiency and viral titer were determined by monitoring fluorescent cells on control plates transduced with a virus expressing the enhanced green fluorescent protein (Clontech). GlyB cells (2 x 10 6 ) were suspended in 9 ml MEM and 7 ml of viral supernatant and plated on each of ten 150 mm dishes; after 5 hours the medium was replaced with complete MEM. After 48 hours at 37°, selection in glycine-free MEM containing dialyzed serum was applied. After 10-14 days, colonies were expanded in glycine-free medium. GlyB rescue hmft cDNA A PCR derived cDNA devoid of Taq polymerase-generated fidelity errors was subcloned into the NotI site of pcDNA3 (Invitrogen). Purified plasmid was transfected into glyB cells as a calcium phosphate precipitate (11, 21) . Two days after transfection, 1 mg/ml G418 was added to medium in the presence or absence of glycine. Plates were refed daily for 14 days, then colonies were fixed and stained.
Northern Blotting RNA was isolated using the Trizol reagent (Life Technologies). Poly-A(+)
RNA was prepared (Qiagen) and 10 µg of poly-A+ mRNA was run in each lane of a MOPSformamide gel (22 with 10 ml of PBS, detached with 5 ml of trypsin and 9 ml of PBS containing 5% FCS were added; cells were pelleted by centrifugation at 900 x G for 10 minutes. The pellet was washed twice with 10 ml of PBS containing FCS and resuspended in 2 ml homogenization solution (HMS, 0.25 M sucrose and 1 mM EDTA); a 0.5 ml aliquot of this suspension was counted for total cellular radioactivity. The remaining suspension was homogenized with 25 strokes in a hand-held Dounce homogenizer and centrifuged at 900 xG for 5 minutes. The post-nuclear supernatant (PNS) was removed, and the pellet (containing nuclei and unbroken cells) was resuspended in 2 ml of HMS and again homogenized. The nuclear pellet was collected at 900 xG for 5 minutes, the supernatant was added to the previous PNS, and the pellet was resuspended in 2 ml of HMS and recentrifuged. The supernatant was again added to the PNS fraction and the nuclear pellet was saved on ice. The PNS was centrifuged first at 900 x G for 5 minutes, the pellet was discarded, and the supernatant was centrifuged for 15 minutes at 10,000
x G. The supernatant (the cytosol fraction) and the pellet (the mitochondrial fraction) were saved. The pelleted fractions were dissolved at 37°C in NaOH, acidified, and added to scintillation vials. Radioactivity in the various fractions was determined by scintillation counting
Results
Complementation of the gly B mutation. Pioneering studies by Puck and his colleagues established four complementation groups among CHO mutants auxotrophic for glycine (16) (17) (18) . One of these complementation groups, defined by the mutation responsible for the glycine auxotrophy of glyB Chinese hamster cells, had a defect in the ability to accumulate folates in mitochondria (15), a process required for the activity of mammalian mitochondrial SHMT (23).
We in the open reading frame (Fig. 2B ). An ATP binding motif (27) was not found. The sequence immediately surrounding the ATG at nt 118-120 in this sequence formed only a fair match to consensus for a mammalian translational initiation codon (28) , about at the level we previously found with a start methionine used by mouse and human cells for translation of mitochondrial folylpolyglutamate synthetase (11, 12) . It was noted that the sequence upstream of the putative translational start methionine was in frame, leaving open the possibility of additional upstream coding region and another upstream start methionine. To address this possibility, 5'-rapid amplification of cDNA ends (RACE) (29) was applied to cDNA prepared from CEM cell RNA.
As much as an additional 54 codons of upstream sequence was detected in these RACE products, but a translational start codon was not found in any frame. Overall, the primary sequence of the protein encoded by this cDNA, which had a molecular mass of 35,387 daltons, suggested that it was an inner mitochondrial membrane transporter that did not require ATP for function.
A GenBank search revealed similarity of the protein encoded by the open reading frame we now report, which we name hmft, with the sequence of several carriers involved in the transport of metabolic intermediates across the inner mitochondrial membrane. The highest homologies were with the yeast flx 1 mitochondrial carrier protein for flavin nucleotides (Genbank protein accession number NP_012132.1) (Fig. 3) , carrier proteins involved in ATP/ADP exchange in rodent and human mitochondria (P12236, P51881, Q09073)( (Table 1) . Hence, the small protein encoded by the single open reading frame in the hmft cDNA complemented the mitochondrial transport function deficient in gly B cells, and simultaneously relieved the prototrophy of these mutants.
Discussion
We herein report the isolation of a novel gene encoding a protein which facilitates the translocation of folates from the cytosol into the mitochondrial matrix of mammalian cells. The cDNA encoding this protein was isolated from a human library by complementation of a mutant cell line which lacked this function (15) . The cDNA complemented both the cellular phenotype, converting transfectants to prototrophy for glycine (Fig. 4) , and the biochemical deficiency, allowing folate transport into mitochondria in transfectants (Table 1 ). This appears to rule out complementation of the auxotrophy by an indirect effect of the expressed gene.
Overall, this manuscript describes the first human protein identified to transport folates or, to our knowledge, any vitamin across the inner mitochondrial membrane (32) . 
PX[D/E]X[L/I/V/A/T][R/K]X[L/R/H]-[L/I/V/M/F/Y][Q/G/A/I/V/M] (24,26,42) which is found
immediately following TM domains 1, 3, and 5. These signals are thought to be required for mitochondrial targeting, translocation across the outer mitochondrial membrane, and insertion into the inner membrane (43, 44) . The hMFT carrier contains three repeat segments each containing a consensus ES motif located precisely after TM domains 1, 3, and 5 ( Fig. 2) .
Interestingly, the first ES motif , located after TM1, is a perfect match to consensus, while the second and third motifs do not have a D or E at position 3. The second motif has a W at position 3 and the third has a Q; these same deviations from the overall consensus is seen for the flx-related family members (Fig 3) . Given that the function of the second and third ES signals It is interesting to note that glyB cells do not accumulate folates in the cytosol to the same extent as do the wild type CHO-K1 cells from which they were derived nor the CHOderived viral transductant or plasmid transfectants with the hmft gene ( Table 1) . This would appear to support the concept that folate polyglutamates made in the mitochondria can support folate metabolism in the cytosol of mammalian cells, apparently by direct transfer of folate polyglutamates intact from the mitochondria. This transfer had been hypothesized (45) on the basis of the fact that the naturally-occurring transcripts for mitochondrial FPGS (11, 12) or, indeed, artificial transcripts constructed by ligation of model mitochondrial leader sequences to human cytosolic FPGS (46) can support both cytosolic and mitochondrial folate metabolism.
At face value, the data of Table 1 suggests that half of the folate pool in the cytosol stems from the activity of mitochondrial FPGS. This raises questions about the ability of folate antimetabolites to use the hMFT and also whether mitochondrial folate polyglutamates use this transporter for efflux to the cytosol.
The fact that mammalian cells which lack folate transport into mitochondria are glycine auxotrophs (15) but can otherwise survive leads to the somewhat surprising conclusion that all mitochondrial folate metabolism can be dispensed with, except for the folate-dependent supply of glycine. The glyB phenotype is not peculiar to these cells: AUXB1 cells, which lack all FPGS activity, can be reconstituted with cDNAs encoding only the cytosolic isoform of FPGS; these transfectants have intact cytosolic folate metabolism but are unable to accumulate folates in the mitochondria and are simple glycine auxotrophs (11, 12) . Apparently, exogenous glycine can be delivered to the mitochondria, presumably through the cytosol, and can facilely penetrate the outer and inner mitochondrial membranes. Hence, the glycine auxotrophy of glyB cells indicates that cytosolic SHMT cannot supply glycine for mitochondrial metabolism at any appreciable concentration. This is in accord with current thought that cytosolic SHMT is kinetically controlled and funnels serine to glycine for the production of 5,10-methylenetetrahydrofolate for cytosolic one carbon metabolism (47); however, other reactions, e.g. de novo purine synthesis and cytosolic protein synthesis, must consume cytosolic glycine as soon as it is produced. It should be noted that the experiments of Taylor 
